Suicide is Second-Leading Cause of Death Among College Athletes
Drug Topics
MAY 20, 2024
Researchers examined the suicide rates of NCAA student-athletes from 2002 to 2022.
2002 Related Topics 
First patient receives new engineered mRNA epigenetic
European Pharmaceutical Review
OCTOBER 28, 2022
revealed the first patient to be dosed with OTX-2002, the first programmable mRNA therapeutic for c-Myc (MYC) oncogene overexpression, which targets cancer cells while sparing healthy cells. OTX-2002 is delivered via lipid nanoparticles (LNPs) and controls the expression of specific genes using epigenetics, a new era of medicine. .
111 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Leprosy potentially endemic in Central Florida
Pharmaceutical Technology
AUGUST 16, 2023
The proportion of cases found in migrants to Florida has decreased significantly since 2002 while cases in US residents has risen.
98 
STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease
STAT
SEPTEMBER 16, 2022
Preliminary results from the study — just the second to show that CRISPR-based gene editing can be delivered systemically and performed in vivo, or inside the body — found that the treatment, NTLA-2002, reduced levels of the disease-causing protein, kallikrein, by 65% and 92% in the low- and high-dose cohort, respectively.
131 
Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma
PharmaShots
MARCH 31, 2023
Shots: The companies collaborated to evaluate the safety, tolerability, PK, PD & preliminary antitumor activity of OTX-2002 as monotx. The preliminary results from the monotx.
Immunization 40
40 Immunization 40
40 
Opinion: What Rosalynn Carter understood about mental health
STAT
NOVEMBER 21, 2023
Often she was called upon to guide, inform, or brainstorm, as she did in 2002 when Mike Hogan, chair of President George W.
133 
Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer’s
STAT
JANUARY 11, 2023
In 2002, toxicologist and neuropathologist Lilian Calderón-Garcidueñas, who grew up east of the metropolis and attended medical school in the city, decided to look at the brains of 40 dogs that had lived either in the city’s polluted valley or in the cleaner air of Tlaxcala, a state on its eastern edge.
Medical Schools 121
121 Medical Schools 121
121 
Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state
Fierce Pharma
MAY 21, 2024
. | Incyte revealed plans to purchase buildings at 1100 North King Street and 1100 North French street in downtown Wilmington, Delaware, where the company got its start back in 2002.
83 
STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug
STAT
OCTOBER 31, 2023
Here’s the backstory: Enbrel was the centerpiece of a 2002 deal in which Amgen acquired another company called Immunex that had developed the medicine. But Public Citizen maintains Medicare officials should consider the ongoing cost of the patenting tactics when negotiating a price.
96 
Key developments: mRNA vaccines and therapeutics
European Pharmaceutical Review
FEBRUARY 14, 2023
OTX-2002, the first mRNA therapy to target c-Myc (MYC) oncogene overexpression, could be the first programmable epigenetic medicine.” ” OTX-2002, the first mRNA therapy to target c-Myc (MYC) oncogene overexpression, could be the first programmable epigenetic medicine, with the potential to generate $1.6
Vaccines 105
105 
Watch: Blockbuster drug Humira has new competition. Here’s why that matters
STAT
FEBRUARY 13, 2023
Humira has been the world’s best-selling medicine since it arrived on the market in 2002. Now, it is finally getting competition with the release of Amgen’s biosimilar drug, Amjevita.
79 
How telehealth startups are trying to fill the menopause care vacuum
STAT
JULY 17, 2023
But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.
78 
Competition is on the horizon for costly narcolepsy treatments
pharmaphorum
DECEMBER 14, 2022
Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. That’s an objectively long time to have exclusivity of a drug that was first synthesised nearly 100 years ago.
FDA 114
114 
Adalimumab biosimilars shaping market, research states
European Pharmaceutical Review
AUGUST 4, 2023
billion in 2022, a product that was launched in 2002. There are at present, nine US Food and Drug Administration (FDA)-approved agents, GlobalData stated. Worldwide sales for Humira peaked at $21.2 percent in the first quarter compared to the same time last year.
FDA 97
97 FDA 97
97 
$2 billion mRNA-based oncology therapy market anticipated by 2029
European Pharmaceutical Review
SEPTEMBER 1, 2023
OTX-2002 from Omega Therapeutics is an mRNA therapy anticipated to generate $658 million in global sales, representing 33.2 It will open new opportunities to boost the potential of mRNA-based therapies by combining them with other ICIs and expanding to other solid tumours, GlobalData stated. “ percent of the total mRNA therapy market by 2029.
Immunization 110
110 
Personalizing the Cancer Patient Journey
Pharma Marketing Network
JULY 27, 2022
Reach out at swhite@xaviercreative.com. Connect at linkedin.com/in/sunnywhite/ . REFERENCES: Organization, World Health. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products. Accessed June 18, 2022. The post Personalizing the Cancer Patient Journey appeared first on Pharma Marketing Network.
Communication 130
130 
Minneceutics Newsletter
Blog: Ask a Student Pharmacist
OCTOBER 4, 2023
Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
52 
Watch: Blockbuster drug Humira has new competition. Here’s why that matters
STAT
FEBRUARY 13, 2023
Humira has been the world’s best-selling medicine since it arrived on the market in 2002. Now, it is finally getting competition with the release of Amgen’s biosimilar drug, Amjevita.
63 
STAT+: Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts
STAT
SEPTEMBER 16, 2022
Preliminary results from the study — just the second to show that CRISPR-based gene editing can be delivered systemically and performed inside the body — found the treatment, NTLA-2002, reduced levels of the disease-causing protein, kallikrein, by 65% and 92% in the low- and high-dose cohort, respectively.
FDA 58
58 FDA 58
58 
Cheryl Barton
pharmaphorum
AUGUST 7, 2024
In 2002, Dr Barton founded PharmaVision to provide independent, tailor-made, life sciences, and consumer health research to pharmaceutical companies, competitive intelligence specialists, investment institutions, and healthcare communication agencies.
mRNA non-vaccine therapeutics to generate $2 billion by 2028
European Pharmaceutical Review
DECEMBER 1, 2022
GlobalData stated that if development is successful for Ultragenyx’s OTX-2002 , which has potential to be the first programmable epigenetic medicine, it could generate $1.6 billion during 2028.
Vaccines 98
98 
Astellas’ nonhormonal hot flashes treatment Veozah wins FDA nod
Pharmaceutical Technology
MAY 15, 2023
In a 2002 WHI study, patients treated with oestrogen and progesterone were reported to have a significantly higher risk of stroke, heart attacks and breast cancer. This includes an increased risk of heart attack, stroke, and breast cancer, amongst others, per the US National Institutes of Health’s National Institute on Aging.
FDA 97
97 FDA 97
97 
Esomeprazole vs Omeprazole – Which one is BETTER?
Druggist
NOVEMBER 17, 2020
It is also suggested than esomeprazole has improved ‘chemical’ properties, which allows controlling acid production for longer than other proton pump inhibitors (Johnson & Hedge, 2002). . 2002 Jul 15;59(14):1333-9. Furthermore, esomeprazole was more effective than omeprazole when used in the treatment of H.
Packaging 87
87 Packaging 87
87 
Booster data backs Pfizer, Valneva Lyme disease vaccine
pharmaphorum
SEPTEMBER 28, 2021
GlaxoSmithKline (then SmithKline Beecham) developed a Lyme disease vaccine called Lymerix back in the 1990s, but it fell foul of anti-vaccine sentiment and the drugmaker eventually pulled it off the market in 2002, after settling a class action lawsuit claiming injuries from side effects.
Vaccines 105
105 Vaccines 105
105 
EU proposes new blood, tissues and cells Regulation
European Pharmaceutical Review
JULY 25, 2022
The new Regulation will replace the rules for safety and quality set out in Directives 2002/98/EC for blood and blood components and 2004/23/EC for tissues and cells, in addition to their implementing acts. .
116 
Healthware Group announces acquisition of Argon Global Healthcare network
pharmaphorum
MARCH 2, 2022
” Established in 2002, Argon Global Healthcare has built a global healthcare agency network covering major markets in EMEA, Americas, and APAC. This robust network comprises independently owned healthcare communications agencies with a proven track record of high performance.
James Cloyd III, Receives Distinguished Tyler Prize
Blog: Ask a Student Pharmacist
JANUARY 29, 2020
The award was established in 1962 as the Stimulation of Research Award and was renamed The Tyler Prize for Stimulation of Research in 2002 in recognition of the distinguished scientific and administrative career of Dr. Varro "Tip" Tyler (1926-2001).
52 
Porterhouse Medical Group joins imc group
pharmaphorum
AUGUST 19, 2020
Founded by Hallows and Brian Parsons in 2002, the Reading, UK-headquartered Porterhouse is a healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
Zovirax Cream for cold sores | Aciclovir (acyclovir) cream
Druggist
SEPTEMBER 15, 2020
Two more extensive studies investigating the effectiveness of aciclovir cream (Zovirax cream) were concluded in 2002. The significant results translate into the following infection times (Spruance et al, 2002): For patients treated with aciclovir cream, the duration of cold sore infection was 4.3 days versus 4.8 days versus 5.2
Labelling 98
98 Labelling 98
98 
Does Zyrtec make you drowsy?
The Checkup by Singlecare
DECEMBER 15, 2023
Food and Drug Administration (2002) Zyrtec-D 12 Hour (cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg) extended-release tablets , U.S. If your allergy symptoms are severe, a healthcare provider can also offer guidance on prescription drugs or allergy shots for allergy relief.
Can you get melatonin over the counter in the UK?
Druggist
FEBRUARY 28, 2021
It also concluded that short-term use of melatonin is safe (Herxheimer & Petrie, 2002). 2002;(2):CD001520. Cochrane concluded that melatonin is ‘remarkably effective’ in preventing or reducing jet-lag. Can you get melatonin over the counter in the UK? In the UK, melatonin is classified as a prescription-only medication.
Insurance 98
98 Insurance 98
98 
Surprise pandemic lessons for pharma
pharmaphorum
JULY 30, 2021
Residents of Southeast Asia who had experienced the SARS outbreak in 2002-04 would likely have had a much better understanding, but even they could not have imagined just how disorganised the response would be in many other parts the world.
Vaccines 52
52 Vaccines 52
52 
Abbas Raza, PhD
Blog: Ask a Student Pharmacist
JUNE 21, 2023
2002, 4(6), 652-655. 2002, 13(4), 423-428. Solid-Phase Synthesis of Isoxazolines. S; Chandrasekhar, S. Synthesis of unusual amino acids: N-(tert-butoxycarbonyl)-L-vinyl glycine and N-(tert-butoxycarbonyl)-L-homophenylalanine. Chandrasekhar, S.
Compounding 52
52 Compounding 52
52 
Is Hormone Therapy Safe for Menopausal Women?
The People's Pharmacy
MAY 18, 2023
That’s because the first really large, randomized controlled trial of HRT was published in 2002 with bad news ( JAMA , July 17, 2002 ). Even before the Women’s Health Initiative (WHI) study was first published in 2002 some women were asking: is hormone therapy safe?
Compounding 57
57 Compounding 57
57 
Valneva’s Lyme disease vaccine faces final clinical test in a sparse landscape
Pharmaceutical Technology
AUGUST 17, 2022
A vaccine called Lymerix , then manufactured by SmithKline Beecham, was approved in the US in 1998 but was quickly withdrawn in 2002 due to insufficient custo mer demand. Lyme disease is also known as borreliosis, which refers to the borrelia bacteria that cause the condition. It is currently treated with antibiotics.
Vaccines 119
119 Vaccines 119
119 
REGiMMUNE Entered into a License Agreement with San Fu Biotech to Develop and Commercialize RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease
PharmaShots
APRIL 3, 2023
REGiMMUNE’s RGI-2001 is currently in P-III trial for the prophylaxis of aGVHD Ref: Businesswire | Image: Regimmune Related News:- Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma
40 
Does acupuncture for diabetes work?
The Checkup by Singlecare
NOVEMBER 11, 2022
between 2002 and 2012. It’s been used for more than 2,500 years to address a multitude of health conditions, and its use has been on the rise in the United States in recent years, too. A national survey found a 50% jump in acupuncture users in the U.S.
116 
Three strategies for managing loss of exclusivity successfully
pharmaphorum
FEBRUARY 18, 2021
6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002. RESULT: As of 2002, 40% of PRILOSEC patients had switched to NEXIUM, which notched up sales of $3.9 Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. billion in 2004.14
A history of blood cancer treatment
pharmaphorum
SEPTEMBER 13, 2022
2002 – Emergence of CAR-T therapy. It wasn’t until 2002, when Memorial Sloane Kettering Cancer Center scientists Michel Sadelain, Renier Brentjens, and Isabelle Rivière opted to push the boundaries of research, by genetically engineering T-cells with a CAR, that the technique achieved successful results.
Chemotherapy 98
98 
Esomeprazole vs Omeprazole – Which one is BETTER?
Druggist
NOVEMBER 17, 2020
It is also suggested than esomeprazole has improved ‘chemical’ properties, which allows controlling acid production for longer than other proton pump inhibitors (Johnson & Hedge, 2002). . 2002 Jul 15;59(14):1333-9. Furthermore, esomeprazole was more effective than omeprazole when used in the treatment of H.
Packaging 52
52 Packaging 52
52 
Using DBS (Deep Brain Stimulation) to Treat Parkinson’s
BuzzRx
AUGUST 24, 2022
Deep brain stimulation was FDA approved to treat Parkinson’s in 2002 following clinical trials. Is DBS FDA-approved for Parkinson’s? Who is the best candidate for DBS surgery?
FDA 98
98 FDA 98
98 
Higher intake of seafood lowers 10-year risk of CVD-related mortality
Hospital Pharmacy Europe
APRIL 26, 2023
High fish intake rich in n-3 polyunsaturated fatty acids reduces cardiovascular disease incidence in healthy adults: The ATTICA cohort study (2002-2022) Front Physiol 2023 The post Higher intake of seafood lowers 10-year risk of CVD-related mortality appeared first on Hospital Pharmacy Europe. Citation Critselis E et al.
Hospitals 52
52 Hospitals 52
52 
A history of Johnson & Johnson
pharmaphorum
FEBRUARY 26, 2021
Weldon became the Chairman and CEO of J&J in 2002. The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 billion the following February. Under his leadership, the company entered new therapeutic areas.
Vaccines 126
126 
Erica Stern, PhD, OTR/L, FAOTA
Blog: Ask a Student Pharmacist
JULY 24, 2023
I have taught OT 6412 Orthotics and Prosthetics; OT 6402 Neurorehabilitation Research: I have taught OT 7201 -Scholarly Inquiry, OT 7494-Scholarly Project, and the campus-wide course for faculty, administration, and research graduate students on Responsible Conduct of Research General: I have taught the OT 6102 – Professional Identity Clinical Clinical (..)
40 
Let's personalize your content